Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 53 of 120 for:    COP1

Natalizumab in Combination With Glatiramer Acetate (GA) in Patients With Relapsing-Remitting Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00097760
Recruitment Status : Completed
First Posted : December 1, 2004
Last Update Posted : June 18, 2009
Sponsor:
Collaborator:
Elan Pharmaceuticals
Information provided by:
Biogen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2004
Actual Study Completion Date : March 2004